CatalystWireBeta

UK small-cap RNS · 11 Mar 2026

Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.

Sort: Newest · Largest companies
  1. 16:23
    Statement on possible offer for Capricorn Energy Offer
    Capricorn confirms multiple unsolicited non-binding all-cash proposals from a Cafani Group member, with due diligence given. Funding is unclear and no firm offer or price is stated, so the outcome is uncertain.
    Takeover target first since Oct 2023 +6.4% on the day
    Moved: new: Possible offer for Capricorn – Approach received; due diligence given; funding unclear
  2. 09:34
    Update on Case Investment and Strategic Review
    Litigation Capital Management Limited ("LCM" or the "Company"), an alternative asset manager specialising in dispute financing solutions internationally, is pleased to announce that its funded party has been successful in the High Court of Australia in a …
    Sale process / strategic review outlook mixed +7.1% on the day
    Moved: Strategic review: Review continuing; waiver extended to 15 April → Review continuing; results delayed to give update
  3. 07:01
    Result of Equity Issue
    Kosmos prices 97.5m new shares at $1.90 ($185.25m gross) to repay RBL and other debt; dilutive, but cuts ~$3.0bn net debt after covenant easing. No discount to a prior price is stated.
    Balance-sheet stress / refinancing £138.1m · 11% of mcapfirst since Oct 2023 −16.3% on the day
    Moved: 2026 and 2027 debt maturities: 2026 notes redeemed; RBL covenant eased → Equity raise priced to repay debt
  4. 07:00
    Bodycote BOY £1,541m
    Final Results Results
    Adjusted profit and margins fell on lower Oil & Gas revenue and weak Automotive and Industrial markets, but H2 Core growth of 3.2%, Optimise savings, an £80m buyback and an outlook for 2026 growth offset this.
    Turnaround plan with targets £19.0m · 1% of mcapoutlook positivefirst since Oct 2023 +7.9% on the day
    Moved: Optimise programme and plant closures: Portfolio reshaping continues with a bolt-on → Well progressed; £4m benefit in 2025, c.£4m more in 2026 · Aerospace and capacity build-out: Adds US A&D capacity via acquisition → Spectrum Thermal Processing acquisition completed early 2026
  5. 07:00
    Update on ICC-2 Annulment Application
    Tunisia missed its response deadline and instead contested the Swiss Court's jurisdiction, but the company concedes annulment applications rarely succeed and a decision is still 6 to 9 months from filing. The ICC-2 award dismissed US$130m of claims.
    Legal & regulatory +15.6% on the day
    Moved: new: ICC-2 annulment application – Awaiting Tunisia's response; jurisdiction contested
  6. 07:00
    ECOVAXXIN® MG favourable USDA safety assessment
    Assessment represents a significant milestone towards US marketing authorisation
    Project milestones +4.2% on the day
    Moved: new: ECOVAXXIN MG US approval – USDA safety assessment favourable
  7. 07:00
    2025 Full-Year Results Results
    Net fees fell 14% in constant currency for a third year of decline, producing an operating loss of £14.9m and no final dividend, though UK, Spain and New Zealand recovered in H2.
    Upgrade / downgrade cycle outlook mixedfirst in 7 months −8.0% on the day
    Moved: Cost savings and portfolio management: Run rate below £24m; £10m target by 2027 → Savings target raised to at least £12m · Market recovery and 2026 NFI: 2026 NFI planned slightly below 2025 → 2026 NFI still slightly below 2025
  8. 07:00
    Final Results Results
    Adjusted operating profit rose to $14.7m from $3.8m on revenue of $123.2m, but the figures include a $14.1m capital gain on the AMS sale. Networks grew 36% while Cyber fell on the 2024 comparatives.
    Disposal of a part (break-up) outlook positivefirst in 6 months +0.3% on the day
    Moved: Exit of non-core assets: Four disposals done; more exits in progress → Five sold; diagnostics now Non-core · AMS diagnostics distributor sale: Sale completed; share transfer pending in January → Completed; reported in full-year results (closed)
  9. 07:00
    Half-year Results Results
    Results match market forecasts, but EPRA EPS fell 10% and dividend cover dropped to 88%, with the company blaming JV cash drag and a one-off refinancing cost. LTV rose to 45%, though the minimum dividend uplift guidance is new.
    Large acquisition / reverse takeover in lineoutlook positive, raised −1.3% on the day
    Moved: Debt-funded UK pipeline deployment: Three UK stores completed; LTV pro-forma 43% → JV proceeds fully redeployed; LTV 43% pro-forma
  10. 07:00
    Final Results Results
    Underlying EBITDA of £278.8m landed inside the £275-280m guidance and above the £276.3m company-compiled consensus, but LFL EBITDA fell 4%, EPS fell and net debt rose after Lionmark. Record FCF and a 15.0p dividend offset this.
    Upgrade / downgrade cycle in lineoutlook mixedfirst since Oct 2023 +4.7% on the day
    Moved: Lionmark integration: Integration continuing → Integration substantially complete, ahead of schedule (closed) · Market recovery timing: Guidance below consensus; recovery timing uncertain → Signs of stabilising UK markets; recovery awaited · new: Peak Cluster carbon capture – Shareholder agreement signed; FEED commenced
  11. 07:00
    Mosaic Agreement and Uberaba Economic Assessment
    Rainbow signs Agreement with the Mosaic Company ("Mosaic") and releases Positive Economic Assessment on the Uberaba Project in Brazil
    Project milestones outlook positive +6.5% on the day
    Moved: Uberaba Economic Assessment: Economic Assessment underway → EA published; Mosaic development agreement signed; PFS next

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note